Envestnet Asset Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $286K | Sell |
15,936
-336
| -2% | -$4.7K | ﹤0.01% | 4454 |
|
|
2026
Q1 | $153K | Buy |
+16,272
| New | +$179K | ﹤0.01% | 4561 |
|
|
2025
Q4 | – | Sell |
-13,238
| Closed | -$190K | – | 4551 |
|
|
2025
Q3 | $190K | Buy |
+13,238
| New | +$181K | ﹤0.01% | 4332 |
|
|
2025
Q2 | – | Sell |
-27,527
| Closed | -$605K | – | 4497 |
|
|
2025
Q1 | $605K | Buy |
27,527
+1,204
| +5% | +$28.3K | ﹤0.01% | 3503 |
|
|
2024
Q4 | $597K | Sell |
26,323
-7,240
| -22% | -$158K | ﹤0.01% | 3489 |
|
|
2024
Q3 | $610K | Sell |
33,563
-18,672
| -36% | -$433K | ﹤0.01% | 3424 |
|
|
2024
Q2 | $1.52M | Sell |
52,235
-4,053
| -7% | -$120K | ﹤0.01% | 2754 |
|
|
2024
Q1 | $2M | Buy |
56,288
+4,956
| +10% | +$198K | ﹤0.01% | 2572 |
|
|
2023
Q4 | $2.24M | Sell |
51,332
-2,019
| -4% | -$79.5K | ﹤0.01% | 2398 |
|
|
2023
Q3 | $2.04M | Sell |
53,351
-1,882
| -3% | -$79.2K | ﹤0.01% | 2366 |
|
|
2023
Q2 | $2.27M | Buy |
55,233
+1,243
| +2% | +$59.8K | ﹤0.01% | 2203 |
|
|
2023
Q1 | $3.1M | Sell |
53,990
-89
| -0.2% | -$5.01K | ﹤0.01% | 1919 |
|
|
2022
Q4 | $3.03M | Sell |
54,079
-3,302
| -6% | -$168K | ﹤0.01% | 1890 |
|
|
2022
Q3 | $2.43M | Sell |
57,381
-445
| -0.8% | -$22.8K | ﹤0.01% | 1965 |
|
|
2022
Q2 | $3.12M | Buy |
57,826
+608
| +1% | +$36.5K | ﹤0.01% | 1811 |
|
|
2022
Q1 | $3.68M | Sell |
57,218
-2,724
| -5% | -$179K | ﹤0.01% | 1794 |
|
|
2021
Q4 | $4.02M | Buy |
59,942
+2,956
| +5% | +$200K | ﹤0.01% | 1717 |
|
|
2021
Q3 | $3.9M | Buy |
56,986
+1,223
| +2% | +$86.4K | ﹤0.01% | 1680 |
|
|
2021
Q2 | $3.81M | Buy |
55,763
+599
| +1% | +$42.4K | ﹤0.01% | 1682 |
|
|
2021
Q1 | $3.81M | Buy |
55,164
+4,672
| +9% | +$317K | ﹤0.01% | 1573 |
|
|
2020
Q4 | $3.28M | Buy |
50,492
+385
| +0.8% | +$20.7K | ﹤0.01% | 1480 |
|
|
2020
Q3 | $2.37M | Sell |
50,107
-3,397
| -6% | -$162K | ﹤0.01% | 1523 |
|
|
2020
Q2 | $2.51M | Buy |
53,504
+591
| +1% | +$29.1K | ﹤0.01% | 1447 |
|
|
2020
Q1 | $2.36M | Buy |
52,913
+1,964
| +4% | +$103K | ﹤0.01% | 1343 |
|
|
2019
Q4 | $2.97M | Buy |
50,949
+2,109
| +4% | +$126K | ﹤0.01% | 1405 |
|
|
2019
Q3 | $2.93M | Buy |
48,840
+1,600
| +3% | +$95.3K | ﹤0.01% | 1335 |
|
|
2019
Q2 | $2.64M | Buy |
47,240
+2,946
| +7% | +$152K | ﹤0.01% | 1389 |
|
|
2019
Q1 | $2.47M | Buy |
44,294
+6,528
| +17% | +$332K | ﹤0.01% | 1364 |
|
|
2018
Q4 | $1.7M | Buy |
+37,766
| New | +$2.07M | ﹤0.01% | 1421 |
|
|
2018
Q3 | – | Sell |
-6,832
| Closed | -$441K | – | 1880 |
|
|
2018
Q2 | $441K | Sell |
6,832
-3,590
| -34% | -$222K | ﹤0.01% | 1370 |
|
|
2018
Q1 | $600K | Sell |
10,422
-3,145
| -23% | -$165K | ﹤0.01% | 1135 |
|
|
2017
Q4 | $649K | Buy |
13,567
+202
| +2% | +$9.89K | ﹤0.01% | 1375 |
|
|
2017
Q3 | $674K | Sell |
13,365
-1,587
| -11% | -$81.5K | ﹤0.01% | 1327 |
|
|
2017
Q2 | $816K | Sell |
14,952
-2,587
| -15% | -$124K | ﹤0.01% | 1270 |
|
|
2017
Q1 | $739K | Sell |
17,539
-6,615
| -27% | -$283K | ﹤0.01% | 1349 |
|
|
2016
Q4 | $1.04M | Buy |
24,154
+1,640
| +7% | +$66.7K | ﹤0.01% | 1169 |
|
|
2016
Q3 | $929K | Buy |
22,514
+7,540
| +50% | +$316K | ﹤0.01% | 1282 |
|
|
2016
Q2 | $597K | Buy |
14,974
+1,062
| +8% | +$38.2K | ﹤0.01% | 1568 |
|
|
2016
Q1 | $469K | Sell |
13,912
-3,264
| -19% | -$102K | ﹤0.01% | 1671 |
|
|
2015
Q4 | $582K | Sell |
17,176
-132
| -0.8% | -$4.13K | ﹤0.01% | 1538 |
|
|
2015
Q3 | $515K | Sell |
17,308
-4,035
| -19% | -$126K | ﹤0.01% | 1582 |
|
|
2015
Q2 | $588K | Buy |
21,343
+237
| +1% | +$6.32K | ﹤0.01% | 1642 |
|
|
2015
Q1 | $532K | Buy |
21,106
+18,231
| +634% | +$431K | ﹤0.01% | 1537 |
|
|
2014
Q4 | $64K | Buy |
+2,875
| New | +$58.3K | ﹤0.01% | 1319 |
|
|
2014
Q3 | – | Sell |
-201
| Closed | -$4K | – | 2802 |
|
|
2014
Q2 | $4K | Buy |
201
+191
| +1,910% | +$3.56K | ﹤0.01% | 2359 |
|
|
2014
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 2594 |
|
|
2013
Q4 | $0 | Sell |
10
-32
| -76% | -$587 | ﹤0.01% | 2495 |
|
|
2013
Q3 | $1K | Sell |
42
-9
| -18% | -$144 | ﹤0.01% | 2280 |
|
|
2013
Q2 | $1K | Buy |
+51
| New | +$747 | ﹤0.01% | 2206 |
|
Other funds holding IART
RCMNY
PCMI
Envestnet Asset Management's IART Position: Q2 2026 in Review
Envestnet Asset Management reduced its Integra LifeSciences (IART) stake by 2.1% in Q2 2026, selling an estimated $4.7K and leaving 15,936 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #4454.
Envestnet Asset Management first reported a position in IART in Q2 2013 and has held it in 49 quarters since. The position peaked at $4.02M in Q4 2021. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Envestnet Asset Management held 15,936 shares of Integra LifeSciences worth $286K as of Q2 2026.
- Envestnet Asset Management sold 336 Integra LifeSciences shares in Q2 2026, an estimated $4.7K.
- Integra LifeSciences made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4454 holding.
- Envestnet Asset Management first reported a position in Integra LifeSciences in Q2 2013 and has held it in 49 quarters since.
- Envestnet Asset Management's Integra LifeSciences position peaked at $4.02M in Q4 2021.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.